OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production from Chinese hamster ovary (CHO) cells is a paramount challenge to the biopharmaceutical industry. A variety of strategies are employed enhance antibody titer, comprising process parameter optimization, media optimization, and implementation of perfusion systems. Fine-tuning culture conditions p